Corbion has successfully secured multiple regulatory approvals from China’s General Administration of Customs (GACC), paving the way for the introduction of its algae-derived omega-3 DHA products into China’s rapidly growing human and animal nutrition markets.

The approvals include key registrations for Corbion’s AlgaPrime™ DHA and AlgaVia™ DHA, two algae-based omega-3 products tailored to meet rising demand in China for sustainable, plant-based nutrition solutions. These products are designed for both animal feed and human health applications, including nutraceuticals and plant-based food.

“China is an important and fast-growing market for algae-derived omega-3 solutions in both food and feed,” said Tim Rutten, Vice President Nutrition & Pharma at Corbion, in a press release. “With these registrations and licenses in place, we can now offer Chinese customers and partners our proven ingredients that align with their focus on quality, safety, and sustainability.”

Produced from microalgae through a controlled fermentation process using sugarcane and renewable energy, AlgaPrime™ DHA and AlgaVia™ DHA offer a clean, highly concentrated, and sustainable source of omega-3. These products help reduce dependency on marine resources and significantly lower carbon footprint, making them a preferred choice for environmentally conscious brands.

Trusted by leading companies across aquaculture, livestock, pet food, and human nutrition, Corbion’s algae-based DHA solutions support omega-3 enrichment, supply chain resilience, and environmental goals. Available in oil, powder, or liquid suspension formats, they provide versatility for a wide range of applications — delivering not just nutritional value but flexible, future-ready solutions.